CHARLES B. HAASER - 10 Feb 2022 Form 4 Insider Report for YIELD10 BIOSCIENCE, INC. (YTEN)

Role: VP Fin and CAO
Signature: /s/ Megan N. Gates, attorney-in-fact
Issuer symbol: YTEN
Transactions as of: 10 Feb 2022
Transactions value $: $21,459
Form type: 4
Filing time: 14 Feb 2022, 13:33:44 UTC
Previous filing: 07 Dec 2021
Next filing: 03 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	YTEN	Common Stock	Award	$21,459	+5,603	+81.9%	$3.83^*	12,442	10 Feb 2022	Direct	F1
holding	YTEN	Common Stock						5,004	10 Feb 2022	By 401(k) Plan	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	YTEN	Stock Option (right to buy)	Award	$0	+18,000		$0.000000	18,000	10 Feb 2022	Common Stock	18,000	$3.83	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The securities awarded are in the form of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 50% of the shares on 8/10/2022 and the remaining 50% on 2/10/2023.
F2	Shares acquired as Issuer matching contributions under the Yield10 Bioscience, Inc. 401(k) Plan.
F3	These options will vest and become exercisable in equal quarterly installments over 4 years from 2/10/2022, beginning on 5/10/2022 and ending on 2/10/2026.